Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients.

Hou X, Liang Y, Chen J, Wei Y, Zeng P, Wang L, Lu C, Diao H.

Biomed Res Int. 2017;2017:6484835. doi: 10.1155/2017/6484835. Epub 2017 Aug 23.

2.

Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells.

Guo X, Guo S, Pan L, Ruan L, Gu Y, Lai J.

Oncol Lett. 2017 May;13(5):3669-3675. doi: 10.3892/ol.2017.5910. Epub 2017 Mar 24.

3.

An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Yoon EL, Yeon JE, Ko E, Lee HJ, Je JH, Yoo YJ, Kang SH, Suh SJ, Kim JH, Seo YS, Yim HJ, Byun KS.

J Korean Med Sci. 2017 Feb;32(2):212-220. doi: 10.3346/jkms.2017.32.2.212.

4.

Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.

Jin K, Li T, Sánchez-Duffhues G, Zhou F, Zhang L.

Oncotarget. 2017 Mar 28;8(13):22145-22165. doi: 10.18632/oncotarget.13530. Review.

5.
6.

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma.

Li L, Diao W, Zen K.

J Hepatocell Carcinoma. 2014 May 21;1:21-33. doi: 10.2147/JHC.S44463. eCollection 2014. Review.

7.

Design of a small molecule against an oncogenic noncoding RNA.

Velagapudi SP, Cameron MD, Haga CL, Rosenberg LH, Lafitte M, Duckett DR, Phinney DG, Disney MD.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5898-903. doi: 10.1073/pnas.1523975113. Epub 2016 May 11.

8.

MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.

Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.

J Transl Med. 2016 May 5;14(1):122. doi: 10.1186/s12967-016-0888-7.

9.

MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.

Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D.

World J Gastroenterol. 2016 Apr 21;22(15):3907-36. doi: 10.3748/wjg.v22.i15.3907. Review.

10.

Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin.

Yang Y, Liu W, Ding R, Xiong L, Dou R, Zhang Y, Guo Z.

PLoS One. 2016 Feb 17;11(2):e0149227. doi: 10.1371/journal.pone.0149227. eCollection 2016.

11.

Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.

Aravalli RN.

Diagnostics (Basel). 2013 Mar 15;3(1):170-91. doi: 10.3390/diagnostics3010170. Review.

12.

Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.

Zhang C, Shu L, Kim H, Khor TO, Wu R, Li W, Kong AN.

Mol Nutr Food Res. 2016 Jun;60(6):1427-36. doi: 10.1002/mnfr.201500918. Epub 2016 May 17.

13.

MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations.

Louten J, Beach M, Palermino K, Weeks M, Holenstein G.

Biomark Insights. 2016 Jan 18;10(Suppl 4):25-52. doi: 10.4137/BMI.S29512. eCollection 2015. Review.

14.

MiR-17~92 ablation impairs liver regeneration in an estrogen-dependent manner.

Zhou Y, Zhang L, Ji H, Lu X, Xia J, Li L, Chen F, Bu H, Shi Y.

J Cell Mol Med. 2016 May;20(5):939-48. doi: 10.1111/jcmm.12782. Epub 2016 Jan 19.

15.

MicroRNA-18a as a promising biomarker for cancer detection: a meta-analysis.

Jin S, Tan SS, Li H.

Int J Clin Exp Med. 2015 Aug 15;8(8):12286-96. eCollection 2015.

16.

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.

Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH.

Exp Mol Med. 2015 Sep 18;47:e184. doi: 10.1038/emm.2015.68.

17.

MicroRNAs as Important Players in Host-hepatitis B Virus Interactions.

Kitab B, Alj HS, Ezzikouri S, Benjelloun S.

J Clin Transl Hepatol. 2015 Jun 28;3(2):149-61. doi: 10.14218/JCTH.2015.00002. Epub 2015 Jun 15. Review.

18.

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.

He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.

Oncotarget. 2015 Oct 6;6(30):28867-81. doi: 10.18632/oncotarget.4814.

19.

Hepatitis B Virus Infection, MicroRNAs and Liver Disease.

Sarkar N, Chakravarty R.

Int J Mol Sci. 2015 Aug 3;16(8):17746-62. doi: 10.3390/ijms160817746. Review.

20.

MiR-17-92 cluster promotes hepatocarcinogenesis.

Zhu H, Han C, Wu T.

Carcinogenesis. 2015 Oct;36(10):1213-22. doi: 10.1093/carcin/bgv112. Epub 2015 Aug 1.

Supplemental Content

Support Center